Search results

Found 718 pages
AUTHOR: Lucy Parsons

Results per page

10 20 50 100

Sort by

Relevance Date

14 Jun 2021:

NICE to reassess Kyowa Kirin’s Poteligeo

An appeal lodged by the company and various charities has been upheld by an independent appeal panel - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/nice_to_reassess_kyowa_kirins_poteligeo_1371577

29 Mar 2021:

GSK, Vir Biotech seek emergency use authorisation for COVID-19…

Companies are requesting emergency approval of drug for the early treatment of COVID-19 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/gsk,_vir_biotech_seek_emergency_use_authorisation_for_covid-19_antibody_1365973

11 Jun 2021:

NICE broadens access to treatments for rheumatoid arthritis

New guidance enables earlier access to certain treatments, including biologics - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/nice_broadens_access_to_treatments_for_rheumatoid_arthritis_1371520

23 Feb 2021:

Sanofi and GSK begin new study of their COVID-19 vaccine

Companies previously delayed vaccine programme in December 2020 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/sanofi_and_gsk_begin_new_study_of_their_covid-19_vaccine_1363891

16 Feb 2021:

LifeArc provides £5m funding for COVID-19 genomics study

Study is aiming to understand the role of genetic risk factors in patient responses to COVID-19 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/lifearc_provides_5m_funding_for_covid-19_genomics_study_1363413

15 Jun 2021:

AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant

New real world data from PHE shows vaccines can protect against hospitalisation caused by variant - News - PharmaTimes

by Lucy Parsons

www.pharmatimes.com/news/az,_pfizerbiontech_vaccines_highly_effective_against_delta_variant_1371652

18 Feb 2021:

UK government pledges £18.5m for long COVID research

Funding will be given to four long COVID research studies - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/uk_government_pledges_18.5m_for_long_covid_research_1363628

4 Mar 2021:

EMA launches rolling review of Russia’s Sputnik V COVID-19 vaccine

Rolling review begins based on lab and clinical studies in adults - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/ema_launches_rolling_review_of_russias_sputnik_v_covid-19_vaccine_1364587

29 Jan 2021:

Novavax COVID-19 vaccine found to be 89.3% effective in UK trial

Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/novavax_covid-19_vaccine_found_to_be_89.3_effective_in_uk_trial_1362314

25 Mar 2021:

AstraZeneca’s updated COVID-19 vaccine trial results show 76% efficacy

Initial results from US trial published earlier this week said the vaccine was 79% effective - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

www.pharmatimes.com/news/astrazenecas_updated_covid-19_vaccine_trial_results_show_76_efficacy_1365819